Edwards Lifesciences Current Ratio 2006-2018 | EW

Current and historical current ratio for Edwards Lifesciences (EW) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Edwards Lifesciences current ratio for the three months ending September 30, 2018 was 2.31.
Edwards Lifesciences Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $2.91B $1.26B 2.31
2018-06-30 $2.70B $1.45B 1.86
2018-03-31 $2.72B $1.32B 2.07
2017-12-31 $2.55B $1.42B 1.80
2017-09-30 $2.57B $0.74B 3.49
2017-06-30 $2.28B $0.56B 4.06
2017-03-31 $2.02B $0.59B 3.45
2016-12-31 $2.24B $0.53B 4.21
2016-09-30 $2.17B $0.53B 4.08
2016-06-30 $1.99B $0.48B 4.15
2016-03-31 $1.82B $0.46B 3.97
2015-12-31 $2.05B $0.48B 4.30
2015-09-30 $2.15B $0.53B 4.03
2015-06-30 $2.30B $0.45B 5.16
2015-03-31 $2.26B $0.41B 5.56
2014-12-31 $2.23B $0.43B 5.24
2014-09-30 $2.31B $0.43B 5.40
2014-06-30 $2.28B $0.54B 4.22
2014-03-31 $1.60B $0.36B 4.50
2013-12-31 $1.73B $0.35B 4.99
2013-09-30 $1.57B $0.34B 4.69
2013-06-30 $1.39B $0.31B 4.43
2013-03-31 $1.36B $0.30B 4.53
2012-12-31 $1.29B $0.35B 3.72
2012-09-30 $1.39B $0.30B 4.65
2012-06-30 $1.28B $0.28B 4.50
2012-03-31 $1.19B $0.27B 4.48
2011-12-31 $1.17B $0.34B 3.49
2011-09-30 $1.18B $0.30B 3.91
2011-06-30 $1.22B $0.31B 3.88
2011-03-31 $1.15B $0.45B 2.58
2010-12-31 $1.03B $0.34B 3.06
2010-09-30 $0.99B $0.38B 2.60
2010-06-30 $0.92B $0.25B 3.71
2010-03-31 $0.87B $0.24B 3.60
2009-12-31 $0.89B $0.29B 3.06
2009-09-30 $0.88B $0.30B 2.96
2009-06-30 $0.75B $0.25B 3.04
2009-03-31 $0.65B $0.20B 3.24
2008-12-31 $0.69B $0.26B 2.68
2008-09-30 $0.68B $0.23B 2.94
2008-06-30 $0.64B $0.23B 2.80
2008-03-31 $0.59B $0.39B 1.51
2007-12-31 $0.59B $0.38B 1.54
2007-09-30 $0.57B $0.35B 1.62
2007-06-30 $0.54B $0.32B 1.67
2007-03-31 $0.54B $0.18B 3.02
2006-12-31 $0.53B $0.23B 2.35
2006-09-30 $0.53B $0.23B 2.31
2006-06-30 $0.54B $0.23B 2.39
2006-03-31 $0.53B $0.20B 2.68
2005-12-31 $0.51B $0.19B 2.65
2005-09-30 $0.43B $0.21B 2.10
2005-06-30 $0.44B $0.19B 2.30
2005-03-31 $0.40B $0.18B 2.27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $30.897B $3.435B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $95.145B 22.17
Intuitive Surgical (ISRG) United States $57.557B 56.63
Fresenius Medical Care AG KGaA (FMS) Germany $24.056B 16.29
IDEXX Laboratories (IDXX) United States $17.145B 48.97
ABIOMED (ABMD) United States $15.217B 109.34
DexCom (DXCM) United States $12.599B 0.00
Teleflex (TFX) United States $11.921B 27.06
Hologic (HOLX) United States $11.149B 18.29
Varian Medical Systems (VAR) United States $10.796B 26.74
STERIS (STE) United Kingdom $10.135B 26.89
Masimo (MASI) United States $5.890B 38.20
LivaNova (LIVN) United Kingdom $5.615B 36.04
Globus Medical (GMED) United States $5.071B 31.86
Penumbra (PEN) United States $4.749B 286.77
Integra LifeSciences Holdings (IART) United States $4.600B 22.41
Wright Medical Group (WMGI) Netherlands $3.691B 0.00
Cantel Medical (CMD) United States $3.469B 34.94
Inogen (INGN) United States $2.988B 64.48
Integer Holdings (ITGR) United States $2.709B 22.67
Halyard Health (AVNS) United States $2.351B 21.18
OPKO Health (OPK) United States $2.085B 0.00
Glaukos (GKOS) United States $1.995B 0.00
Tandem Diabetes Care (TNDM) United States $1.877B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
AxoGen (AXGN) United States $1.290B 0.00
Nevro (NVRO) United States $1.232B 0.00
Luminex (LMNX) United States $1.174B 42.48
Pacific Biosciences Of California (PACB) United States $1.139B 0.00
Orthofix (OFIX) United States $1.129B 32.60
Tactile Systems Technology (TCMD) United States $1.125B 179.18
CryoLife (CRY) United States $1.088B 95.42
Natus Medical (BABY) United States $1.009B 21.18
Intersect ENT (XENT) United States $0.909B 0.00
Accelerate Diagnostics (AXDX) United States $0.785B 0.00
AngioDynamics (ANGO) United States $0.783B 27.40
Mesa Laboratories (MLAB) United States $0.765B 45.22
TransEnterix (TRXC) United States $0.646B 0.00
Veracyte (VCYT) United States $0.544B 0.00
Sientra (SIEN) United States $0.504B 0.00
ViewRay (VRAY) United States $0.460B 0.00
SI-BONE INC (SIBN) United States $0.422B 0.00
Accuray (ARAY) United States $0.413B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.410B 0.00
Neuronetics (STIM) United States $0.387B 0.00
OrthoPediatrics (KIDS) United States $0.340B 0.00
Quotient (QTNT) Switzerland $0.332B 0.00
SeaSpine Holdings (SPNE) United States $0.318B 0.00
Nuvectra (NVTR) United States $0.307B 0.00
Fluidigm (FLDM) United States $0.298B 0.00
RTI Surgical (RTIX) United States $0.286B 45.00
IRadimed (IRMD) United States $0.278B 72.54
GenMark Diagnostics (GNMK) United States $0.247B 0.00
Corindus Vascular Robotics (CVRS) United States $0.243B 0.00
CRH Medical (CRHM) Canada $0.239B 41.25
Helius Medical Technologies (HSDT) United States $0.233B 0.00
Pulse Biosciences (PLSE) United States $0.223B 0.00
T2 Biosystems (TTOO) United States $0.214B 0.00
Ekso Bionics Holdings (EKSO) United States $0.132B 0.00
Alphatec Holdings (ATEC) United States $0.127B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.108B 0.00
Second Sight Medical Products (EYES) United States $0.106B 0.00
Ra Medical Systems (RMED) United States $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.100B 0.00
Apollo Endosurgery (APEN) United States $0.086B 0.00
Restoration Robotics (HAIR) United States $0.076B 0.00
Biosig Technologies (BSGM) United States $0.070B 0.00
Viveve Medical (VIVE) United States $0.068B 0.00
EDAP TMS (EDAP) France $0.068B 0.00
Electromed (ELMD) United States $0.054B 27.13
OBALON THERPTCS (OBLN) United States $0.046B 0.00
Xtant Medical Holdings (XTNT) United States $0.041B 0.00
Vermillion (VRML) United States $0.038B 0.00
Neovasc (NVCN) Canada $0.037B 0.00
ConforMIS (CFMS) United States $0.036B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.034B 0.00
PAVmed (PAVM) United States $0.029B 0.00
Lianluo Smart (LLIT) China $0.029B 0.00
DarioHealth (DRIO) Israel $0.029B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
ReWalk Robotics (RWLK) Israel $0.022B 0.00
ENDRA Life Sciences (NDRA) United States $0.022B 0.00
American Shared Hospital Services (AMS) United States $0.017B 12.70
Nanovibronix (NAOV) United States $0.016B 0.00
Bioanalytical Systems (BASI) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Presbia (LENS) Ireland $0.013B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.009B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
Avinger (AVGR) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Amedica (SINT) United States $0.000B 0.00